Gland Pharma shares rally 6% as brokerages lift ratings, target prices ; here's (...)
Gland Pharma shares surged after strong Q1 results and positive commentary from brokerages citing a turnaround at its European unit Cenexi. EBITDA margins expanded to 24.4%, and net profit rose 50% YoY. Despite weak U.S. sales, growth in Europe and new launches supported the outlook. Brokerages (...)
Site référencé: The Economic Times
The Economic Times
How will Trump's tariff announcement impact Indian stock market ?
31/07/2025
Maximize Your Returns : Can multi-asset funds outperform traditional equity investments ?
31/07/2025
Rupee may hit record lows following US tariff shock
31/07/2025
Piramal Enterprises Q1 Results : Net profit surges 52% to Rs 276 crore on improved margins, lower credit costs
30/07/2025
